|
(2S,4S,5R,6R)- 5- Acetamido- 2- [(2S,3R,4R,5S,6R)- 3- acetamido- 2- [(2R,3S,4S,5R,6S)- 3,5- dihydroxy- 2- (hydroxymethyl)- 6- [(2R,3S,4R,5R,6R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 5- hydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid |
|
CHEBI:150267 |
|
 
This entity has been manually annotated by a third party.
|
|
Gareth Owen
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C31H52N2O24/c1- 8(38) 32- 15- 10(40) 3- 31(30(49) 50,56- 24(15) 17(42) 11(41) 4- 34) 57- 25- 16(33- 9(2) 39) 28(52- 12(5- 35) 18(25) 43) 55- 26- 19(44) 13(6- 36) 53- 29(22(26) 47) 54- 23- 14(7- 37) 51- 27(48) 21(46) 20(23) 45/h10- 29,34- 37,40- 48H,3- 7H2,1- 2H3,(H,32,38) (H,33,39) (H,49,50) /t10- ,11+,12+,13+,14+,15+,16+,17+,18+,19- ,20+,21+,22+,23+,24+,25+,26- ,27+,28- ,29- ,31- /m0/s1 |
FUSISFDFJVGXQI-MVZCQNFISA-N |
O([C@@H] 1[C@@H] (NC(=O) C) [C@H] (O[C@@H] 2[C@@H] (O) [C@@H] (O[C@@H] ([C@@H] 2O) CO) O[C@H] 3[C@H] (O) [C@@H] (O) [C@@H] (O[C@@H] 3CO) O) O[C@@H] ([C@H] 1O) CO) [C@] 4(O[C@H] ([C@H] (NC(=O) C) [C@@H] (O) C4) [C@H] (O) [C@H] (O) CO) C(O) =O |
|
Outgoing
|
(2S,4S,5R,6R)- 5- Acetamido- 2- [(2S,3R,4R,5S,6R)- 3- acetamido- 2- [(2R,3S,4S,5R,6S)- 3,5- dihydroxy- 2- (hydroxymethyl)- 6- [(2R,3S,4R,5R,6R)- 4,5,6- trihydroxy- 2- (hydroxymethyl)oxan- 3- yl]oxyoxan- 4- yl]oxy- 5- hydroxy- 6- (hydroxymethyl)oxan- 4- yl]oxy- 4- hydroxy- 6- [(1R,2R)- 1,2,3- trihydroxypropyl]oxane- 2- carboxylic acid
(CHEBI:150267)
is a
neuraminic acids
(CHEBI:25508)
|
|
5- acetamido- 3,5- dideoxy- D- glycero- alpha- D- galacto- non- 2- ulopyranosylonic acid- (2- >3)- 2- acetamido- 2- deoxy- beta- D- gluco- hexopyranosyl- (1- >3)- beta- D- galacto- hexopyranosyl- (1- >4)- beta- D- gluco- hexopyranose
|
SUBMITTER
|
NeuAc(a2-3)GlcNAc(b1-3)Gal(b1-4)b-Glc
|
SUBMITTER
|
WURCS=2.0/4,4,3/[a2122h- 1b_1- 5][a2112h- 1b_1- 5][a2122h- 1b_1- 5_2*NCC/3=O][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3- 4/a4- b1_b3- c1_c3- d2
|
SUBMITTER
|
|